Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Anavex Life Sciences | AVXL | Jan 15, 2025 | 11.33 | +8.21 |
Andretti Acquisition II | POLE | Jan 15, 2025 | 10.01 | 0.00 |
Andretti Acquisition II Unit | POLEU | Jan 15, 2025 | 10.07 | 0.00 |
Anebulo Pharmaceuticals | ANEB | Jan 15, 2025 | 1.66 | +3.73 |
Angel Oak Financial Strategies | FINS | Jan 15, 2025 | 13.25 | +0.53 |
Angel Oak Mortgage REIT | AOMR | Jan 15, 2025 | 9.71 | +0.94 |
Anghami | ANGH | Jan 15, 2025 | 0.72 | -4.00 |
Angi A | ANGI | Jan 15, 2025 | 1.82 | +7.06 |
AngioDynamics | ANGO | Jan 15, 2025 | 12.17 | +3.14 |
Anglogold Ashanti | AU | Jan 15, 2025 | 27.18 | +2.95 |
Anheuser-Busch InBev ADR | BUD | Jan 15, 2025 | 46.46 | -0.06 |
ANI Pharmaceuticals | ANIP | Jan 15, 2025 | 56.55 | +4.41 |
Anika Therapeutics | ANIK | Jan 15, 2025 | 16.02 | +2.82 |
Anixa Biosciences | ANIX | Jan 15, 2025 | 2.28 | +7.04 |
Annaly Capital Management | NLY | Jan 15, 2025 | 18.73 | +1.85 |
Annaly Capital Management F Pref | NLY-F | Jan 15, 2025 | 25.50 | 0.00 |
Annaly Capital Management G Pref | NLY-G | Jan 15, 2025 | 25.42 | +0.28 |
Annaly Capital Management I Pref | NLY-I | Jan 15, 2025 | 25.57 | +0.39 |
Annexon | ANNX | Jan 15, 2025 | 4.24 | -6.40 |
Annovis Bio | ANVS | Jan 15, 2025 | 4.82 | +3.21 |
ANSYS | ANSS | Jan 15, 2025 | 343.07 | +1.03 |
Antelope Enterprise | AEHL | Jan 15, 2025 | 0.17 | +3.64 |
Anteris Technologies Global | AVR | Jan 15, 2025 | 5.87 | 0.00 |
Anterix | ATEX | Jan 15, 2025 | 27.73 | -0.75 |
Antero Midstream | AM | Jan 15, 2025 | 16.17 | +0.25 |
Antero Resources | AR | Jan 15, 2025 | 40.23 | +4.25 |
Anywhere Real Estate | HOUS | Jan 15, 2025 | 3.37 | +11.96 |
Aon | AON | Jan 15, 2025 | 361.18 | -0.41 |
APA | APA | Jan 15, 2025 | 25.45 | +2.41 |
Apartment Investment and Management | AIV | Jan 15, 2025 | 9.12 | +2.59 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.